| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Satchi-Fainaro Ronit is a Director at TEVA. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $4.2M at current prices.
Satchi-Fainaro Ronit's largest disclosed position is in TEVA as Director, worth about $4.2M. The recent filings there lean toward selling, a net 415 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | TEVA Teva Pharmaceutical Industries Limited | Director | Sell | 415 | $37.25 | $15,458.75 | -0.4% |